Moexipril hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for moexipril hydrochloride and what is the scope of freedom to operate?

Moexipril hydrochloride is the generic ingredient in two branded drugs marketed by Apotex Inc, Chartwell Rx, Glenmark Pharms Ltd, Teva, and Ucb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for moexipril hydrochloride. Two suppliers are listed for this compound.

Summary for moexipril hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	5
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	59
Clinical Trials:	6
Patent Applications:	1,746
What excipients (inactive ingredients) are in moexipril hydrochloride?	moexipril hydrochloride excipients list
DailyMed Link:	moexipril hydrochloride at DailyMed

Recent Clinical Trials for moexipril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Nebraska	Phase 4
Teva Pharmaceuticals USA	Phase 1
Mayo Clinic	Phase 2

See all moexipril hydrochloride clinical trials

Pharmacology for moexipril hydrochloride

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for moexipril hydrochloride

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for moexipril hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	076204-001	May 8, 2003	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex Inc	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	078454-001	Jun 2, 2008	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glenmark Pharms Ltd	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	090416-001	Mar 30, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	077536-002	Nov 30, 2006	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-001	Apr 19, 1995		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	077536-001	Nov 30, 2006	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for moexipril hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-002	Apr 19, 1995	⤷ Sign Up	⤷ Sign Up
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-001	Apr 19, 1995	⤷ Sign Up	⤷ Sign Up
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-002	Apr 19, 1995	⤷ Sign Up	⤷ Sign Up
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-001	Apr 19, 1995	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.